- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Fermenta Biotech Limited has shared its Investor Presentation for the third quarter and nine months ended FY26. For 9moFY26, revenue increased 25% to INR 421.2 crore, EBITDA rose 20% to INR 97.2 crore, and Profit After Tax grew 20% to INR 51.7 crore. Q3FY26 saw a moderation in profitability year-on-year due to a high base from prior-year real estate income. However, the company highlighted sequential revenue improvement in Q3 and strong 9-month growth, reaffirming its operational strength. Key drivers include robust volume growth in human (up 46%) and animal nutrition (up 52%) segments, and increased green chemistry sales.